Nextage Therapeutics (XTAE:NXTG) Long-Term Debt : ₪0.00 Mil (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Long-Term Debt?

Nextage Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2023 was ₪0.00 Mil.

Nextage Therapeutics's quarterly Long-Term Debt declined from Dec. 2022 (₪0.12 Mil) to Jun. 2023 (₪0.04 Mil) and declined from Jun. 2023 (₪0.04 Mil) to Dec. 2023 (₪0.00 Mil).

Nextage Therapeutics's annual Long-Term Debt declined from Dec. 2021 (₪1.12 Mil) to Dec. 2022 (₪0.12 Mil) and declined from Dec. 2022 (₪0.12 Mil) to Dec. 2023 (₪0.00 Mil).

Nextage Therapeutics Long-Term Debt Historical Data

The historical data trend for Nextage Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Long-Term Debt Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

1.30

0.55

1.12

0.12

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial									1.12	0.38	0.12	0.04	-

Nextage Therapeutics (XTAE:NXTG) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Nextage Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021